A study of a new hepatitis C vaccine for healthy adults
Part of Digestive system, Infections clinical trials.
This study tests a new vaccine designed to prevent hepatitis C, a virus that affects the liver. The goal is to see if the vaccine is safe, and to understand how the body's immune system responds to it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- You must be in good general health and not smoke.
- You must not have hepatitis C or a history of it.
- You must not have serious long-term conditions like heart disease, autoimmune disease, insulin-dependent diabetes, or untreated asthma.
- You must not be taking medications that weaken the immune system (like high-dose steroids).
- You must agree to use effective birth control if you could become pregnant, and avoid donating blood during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new hepatitis A vaccine in healthy people aged 1 year and older. It aims to see how well the vaccine prevents hepatitis A and checks for any side effects.
This trial tests an investigational drug called IB-001 to see how well it works and how safe it is. It is for healthy volunteers and people with chronic hepatitis B. The goal is to find the best dose and understand side effects.
This trial tests a new vaccine to treat chronic hepatitis B. It's for people who have been on antiviral medication for at least 6 months and still have a low level of the virus in their blood.
This study tests an investigational injection called TVAX-008 for people with chronic hepatitis B. It aims to see if the treatment can help clear the hepatitis B surface antigen, which may lead to a functional cure. The study is for people who have been on antiviral therapy and have well-controlled virus levels.
This study tests a new injectable drug (VH4011499) for safety and how the body processes it. It's for healthy adults without HIV, and participants will get either the study drug or a placebo (an inactive shot).
This study checks whether a single dose of the hepatitis A vaccine helps protect people with cirrhosis who have no immunity. It aims to see how well the vaccine works and your body's response.
Hear when a new Hepatitis C trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.